Clinical Trials Contact

About this Clinical Trial

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Your Message Will Go To

Maria Iglesias

650-723-4247


All fields are required. *

Preferred contact method*

To:

Maria Iglesias

650-723-4247



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine